258 related articles for article (PubMed ID: 28731045)
21. Expression of fibronectin and HIF-1alpha in renal cell carcinomas: relationship to von Hippel-Lindau gene inactivation.
He Z; Liu S; Guo M; Mao J; Hughson MD
Cancer Genet Cytogenet; 2004 Jul; 152(2):89-94. PubMed ID: 15262424
[TBL] [Abstract][Full Text] [Related]
22. Renal Cell Carcinoma with Clear Cell Papillary Features: Perspectives of a Differential Diagnosis.
Somorácz Á; Kuthi L; Micsik T; Jenei A; Hajdu A; Vrabély B; Rásó E; Sápi Z; Bajory Z; Kulka J; Iványi B
Pathol Oncol Res; 2020 Jul; 26(3):1767-1776. PubMed ID: 31656019
[TBL] [Abstract][Full Text] [Related]
23. Renal cell carcinoma with areas mimicking renal angiomyoadenomatous tumor/clear cell papillary renal cell carcinoma.
Petersson F; Grossmann P; Hora M; Sperga M; Montiel DP; Martinek P; Gutierrez ME; Bulimbasic S; Michal M; Branzovsky J; Hes O
Hum Pathol; 2013 Jul; 44(7):1412-20. PubMed ID: 23434146
[TBL] [Abstract][Full Text] [Related]
24. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
[TBL] [Abstract][Full Text] [Related]
25. Cytogenetic studies of 24 renal epithelial tumors with von Hippel-Lindau and fragile histidine triad protein expression correlation.
Gayrard N; Cacheux V; Iborra F; Mourad G; Argilés A
Arch Pathol Lab Med; 2008 Jun; 132(6):965-73. PubMed ID: 18517280
[TBL] [Abstract][Full Text] [Related]
26. Unique molecular alteration patterns in von Hippel-Lindau (VHL) gene in a cohort of sporadic renal cell carcinoma patients from Pakistan.
Khaliq S; Ajaz S; Firasat S; Shahid S; Hasan AS; Sultan G; Mohsin R; Hashmi A; Mubarak M; Naqvi SA; Rizvi SA; Mehdi SQ; Abid A
Mutat Res; 2014; 763-764():45-52. PubMed ID: 24727139
[TBL] [Abstract][Full Text] [Related]
27. Biallelic ELOC-Inactivated Renal Cell Carcinoma: Molecular Features Supporting Classification as a Distinct Entity.
Batavia AA; Rutishauser D; Sobottka B; Schraml P; Beerenwinkel N; Moch H
Mod Pathol; 2023 Aug; 36(8):100194. PubMed ID: 37088333
[TBL] [Abstract][Full Text] [Related]
28. Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney.
Beroukhim R; Brunet JP; Di Napoli A; Mertz KD; Seeley A; Pires MM; Linhart D; Worrell RA; Moch H; Rubin MA; Sellers WR; Meyerson M; Linehan WM; Kaelin WG; Signoretti S
Cancer Res; 2009 Jun; 69(11):4674-81. PubMed ID: 19470766
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of tumorigenesis of renal carcinomas associated with the constitutional chromosome 3;8 translocation.
Schmidt L; Li F; Brown RS; Berg S; Chen F; Wei MH; Tory K; Lerman I; Zbar B
Cancer J Sci Am; 1995; 1(3):191-5. PubMed ID: 9166475
[TBL] [Abstract][Full Text] [Related]
30. Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution.
Fisher R; Horswell S; Rowan A; Salm MP; de Bruin EC; Gulati S; McGranahan N; Stares M; Gerlinger M; Varela I; Crockford A; Favero F; Quidville V; André F; Navas C; Grönroos E; Nicol D; Hazell S; Hrouda D; O'Brien T; Matthews N; Phillimore B; Begum S; Rabinowitz A; Biggs J; Bates PA; McDonald NQ; Stamp G; Spencer-Dene B; Hsieh JJ; Xu J; Pickering L; Gore M; Larkin J; Swanton C
Genome Biol; 2014 Aug; 15(8):433. PubMed ID: 25159823
[TBL] [Abstract][Full Text] [Related]
31. Renal Cell Carcinoma With Leiomyomatous Stroma: A Group of Tumors With Indistinguishable Histopathologic Features, But 2 Distinct Genetic Profiles: Next-Generation Sequencing Analysis of 6 Cases Negative for Aberrations Related to the VHL gene.
Petersson F; Martinek P; Vanecek T; Pivovarcikova K; Peckova K; Ondic O; Perez-Montiel D; Skenderi F; Ulamec M; Nenutil R; Hora M; Svoboda T; Rotterova P; Dusek M; Michal M; Hes O
Appl Immunohistochem Mol Morphol; 2018 Mar; 26(3):192-197. PubMed ID: 29084058
[TBL] [Abstract][Full Text] [Related]
32. Molecular genetics of clear-cell renal cell carcinoma.
Brugarolas J
J Clin Oncol; 2014 Jun; 32(18):1968-76. PubMed ID: 24821879
[TBL] [Abstract][Full Text] [Related]
33. "Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity.
Shah RB; Stohr BA; Tu ZJ; Gao Y; Przybycin CG; Nguyen J; Cox RM; Rashid-Kolvear F; Weindel MD; Farkas DH; Trpkov K; McKenney JK
Am J Surg Pathol; 2020 May; 44(5):571-581. PubMed ID: 31850909
[TBL] [Abstract][Full Text] [Related]
34. Exploration of Morphological Features of Clear Cell Renal Cell Carcinoma With
Liu Y; Li Y; Xu H; Zhou L; Yang X; Wang C
Int J Surg Pathol; 2023 Dec; 31(8):1485-1494. PubMed ID: 36911986
[TBL] [Abstract][Full Text] [Related]
35. VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.
Brauch H; Weirich G; Brieger J; Glavac D; Rödl H; Eichinger M; Feurer M; Weidt E; Puranakanitstha C; Neuhaus C; Pomer S; Brenner W; Schirmacher P; Störkel S; Rotter M; Masera A; Gugeler N; Decker HJ
Cancer Res; 2000 Apr; 60(7):1942-8. PubMed ID: 10766184
[TBL] [Abstract][Full Text] [Related]
36. Specific genomic aberrations predict survival, but low mutation rate in cancer hot spots, in clear cell renal cell carcinoma.
Köhn L; Svenson U; Ljungberg B; Roos G
Appl Immunohistochem Mol Morphol; 2015; 23(5):334-42. PubMed ID: 24992170
[TBL] [Abstract][Full Text] [Related]
37. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
Zbar B
Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
[TBL] [Abstract][Full Text] [Related]
38. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
[TBL] [Abstract][Full Text] [Related]
39. PBRM1 and VHL expression correlate in human clear cell renal cell carcinoma with differential association with patient's overall survival.
Högner A; Krause H; Jandrig B; Kasim M; Fuller TF; Schostak M; Erbersdobler A; Patzak A; Kilic E
Urol Oncol; 2018 Mar; 36(3):94.e1-94.e14. PubMed ID: 29169846
[TBL] [Abstract][Full Text] [Related]
40. Re-evaluation of histological type by immunohistochemical and genetic study of transcription factors (TFE3 and TFEB) of VHL gene mutation-negative clear cell renal cell carcinoma and other special types of renal tumor.
Kuroda N; Kawada C; Tamura K; Hiroi M; Hes O; Michal M; Wada Y; Inoue K; Ohara M; Mizuno K; Shuin T; Lee GH
Med Mol Morphol; 2011 Mar; 44(1):46-51. PubMed ID: 21424937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
